SHC Sotera Health

Sotera Health to Present at Upcoming Healthcare Conferences

Sotera Health to Present at Upcoming Healthcare Conferences

CLEVELAND, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that Chief Financial Officer, Scott Leffler, will present at the Citi 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference on February 24, 2021 at 8:00 am ET. In addition, Chairman and Chief Executive Officer, Michael B. Petras, Jr. will present at the Barclays Global Healthcare Conference on March 10, 2021 at 9:10 am ET.

A link to the live and archived webcast may be accessed on the Sotera Health website under the Investor Relations section: .

About Sotera Health:

Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.

INVESTOR RELATIONS CONTACTS:



Sally J. Curley, IRC

Curley Global IR, LLC







Jenny Kobin

IR Advisory Solutions



  
MEDIA CONTACT:



Kristin Gibbs

Chief Marketing Officer, Sotera Health

 

Source: Sotera Health Company

 



EN
16/02/2021

Underlying

SHCSotera Health

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Sotera Health

 PRESS RELEASE
Free
SHC SOTERA HEALTH

Sotera Health Announces Second-Quarter 2025 Earnings Release Date

Sotera Health Announces Second-Quarter 2025 Earnings Release Date CLEVELAND, July 28, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced it will release its financial results for the second-quarter ended June 30, 2025 before the market opens on Friday, August 8, 2025. Following the release, management will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss the Company’s financial results and operati...

21h / 59m 1 EN
 PRESS RELEASE
Free
SHC SOTERA HEALTH

Sotera Health Reports First-Quarter 2025 Results

Sotera Health Reports First-Quarter 2025 Results Q1 2025 net revenues increased 2.6% to $255 million, compared to Q1 2024, or 4.4% on a constant currency basisQ1 2025 net loss of $13 million or $0.05 per diluted share, compared to net income of $6 million or $0.02 per diluted share in Q1 2024Q1 2025 Adjusted EBITDA(1) increased 8.8% to $122 million, compared to Q1 2024, or 11.2% on a constant currency basisQ1 2025 Adjusted EPS(1) of $0.14, an increase of $0.01 per diluted share, compared to Adjusted EPS of $0.13 in Q1 2024Company reaffirms full-year 2025 outlook of 4.0% - 6.0% net revenues ...

May 1, 2025 1 EN
 PRESS RELEASE
Free
SHC SOTERA HEALTH

Sotera Health Announces First-Quarter 2025 Earnings Release Date

Sotera Health Announces First-Quarter 2025 Earnings Release Date CLEVELAND, April 17, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced it will release its financial results for the first-quarter ended March 31, 2025 before the market opens on Thursday, May 1, 2025. Following the release, management will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss the Company’s financial results and operatin...

April 17, 2025 1 EN
 PRESS RELEASE
Free
SHC SOTERA HEALTH

Nelson Labs Launches Innovative Rapid Sterility Testing to Significant...

Nelson Labs Launches Innovative Rapid Sterility Testing to Significantly Expedite Product Sterility Results Rapid Sterility Testing yields product sterility test results in as little as 6 days and can be used for broadscale medical device and pharmaceutical product application SALT LAKE CITY, March 04, 2025 (GLOBE NEWSWIRE) -- Nelson Labs, a Sotera Health company and a global leader in microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries, now performs product-sterility testing through rapid microbiological methods (R...

March 4, 2025 1 EN
 PRESS RELEASE
Free
SHC SOTERA HEALTH

Sotera Health Reports Fourth-Quarter and Full-Year 2024 Results; Provi...

Sotera Health Reports Fourth-Quarter and Full-Year 2024 Results; Provides 2025 Outlook 2024 net revenues increased 4.9% to $1.10 billion, compared to 2023; or 5.4% on a constant currency basis2024 net income of $44 million or $0.16 per diluted share, compared to 20232024 Adjusted EBITDA(1) increased 3.9% to $549 million, compared to 2023; or 4.6% on a constant currency basis2024 Adjusted EPS(1) of $0.70, a decrease of $0.02 per diluted share, compared to 2023Full-year 2025 outlook of 4.0% - 6.0% net revenues growth and 4.5% - 6.5% Adjusted EBITDA growth, both on a constant currency basis C...

February 27, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch